Cargando…

Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)

OBJECTIVE: Quality of life data in cancerology are often difficult to summarize due to missing data and difficulty to analyze the pattern of evolution in different groups of patients. The aim of this work was to apply a new methodology to construct Quality of Life (QoL) change patterns within patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuemi, Gillles, Devilliers, Hervé, Le Malicot, Karine, Guimbaud, Rosine, Lepage, Côme, Quantin, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578418/
https://www.ncbi.nlm.nih.gov/pubmed/26391356
http://dx.doi.org/10.1186/s12955-015-0342-1
_version_ 1782391116060950528
author Nuemi, Gillles
Devilliers, Hervé
Le Malicot, Karine
Guimbaud, Rosine
Lepage, Côme
Quantin, Catherine
author_facet Nuemi, Gillles
Devilliers, Hervé
Le Malicot, Karine
Guimbaud, Rosine
Lepage, Côme
Quantin, Catherine
author_sort Nuemi, Gillles
collection PubMed
description OBJECTIVE: Quality of life data in cancerology are often difficult to summarize due to missing data and difficulty to analyze the pattern of evolution in different groups of patients. The aim of this work was to apply a new methodology to construct Quality of Life (QoL) change patterns within patients included in a clinical trial comparing to regimen of treatment in locally advanced eosogastric cancer. MATERIALS AND METHODS: In this trial, QoL was assessed every 2 months by self-reported EORTC QLQ-C30 questionnaire. Physical dimension scores were analyzed. After multiple imputation of missing data, 27 statistical measures aiming to describe the variation of QoL measures among follow-up were computed for each patient. Based on these measures, patient were grouped into homogenous groups in terms of QoL variation pattern using a K-Means classification method. The mean QoL score at each time was graphically represented in each obtained pattern. Finally, clinical characteristic of patients in each pattern of QoL were described and compared. RESULTS: The trial included 416 patients and 1023 questionnaire were collected. 74 % of patients were male with a mean ± SD age of 62 ± 11 years. 43 % of scores were missing. Patients were grouped into four classes of homogeneous QoL variation patterns. 1) a Pattern of 24 (6 %) patients showing improvement in QoL with a mean variation of +10.7 points on the 0–100 scale, 2) a Pattern of 171 (41 %) patients showing a stability 3) two Patterns of 78 (19 %) and 143 (34 %) patients respectively showing a deterioration of QoL with a mean variation of −67.2 and −67.6, respectively. There were no difference between patterns in terms of gender or age. Patients within “degradation” pattern had significantly lower performance status (p = 0.015), higher severe after-effects rate (p < 10-3) and death rate (p < 10-3). CONCLUSION: This work opens up perspectives for longitudinal data analysis with a high probability of missing values while providing a relevant graphical summary. Patterns of QoL evolution with clinical relevance may help to interpret longitudinal QoL data in Cancer studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-015-0342-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4578418
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45784182015-09-23 Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307) Nuemi, Gillles Devilliers, Hervé Le Malicot, Karine Guimbaud, Rosine Lepage, Côme Quantin, Catherine Health Qual Life Outcomes Research OBJECTIVE: Quality of life data in cancerology are often difficult to summarize due to missing data and difficulty to analyze the pattern of evolution in different groups of patients. The aim of this work was to apply a new methodology to construct Quality of Life (QoL) change patterns within patients included in a clinical trial comparing to regimen of treatment in locally advanced eosogastric cancer. MATERIALS AND METHODS: In this trial, QoL was assessed every 2 months by self-reported EORTC QLQ-C30 questionnaire. Physical dimension scores were analyzed. After multiple imputation of missing data, 27 statistical measures aiming to describe the variation of QoL measures among follow-up were computed for each patient. Based on these measures, patient were grouped into homogenous groups in terms of QoL variation pattern using a K-Means classification method. The mean QoL score at each time was graphically represented in each obtained pattern. Finally, clinical characteristic of patients in each pattern of QoL were described and compared. RESULTS: The trial included 416 patients and 1023 questionnaire were collected. 74 % of patients were male with a mean ± SD age of 62 ± 11 years. 43 % of scores were missing. Patients were grouped into four classes of homogeneous QoL variation patterns. 1) a Pattern of 24 (6 %) patients showing improvement in QoL with a mean variation of +10.7 points on the 0–100 scale, 2) a Pattern of 171 (41 %) patients showing a stability 3) two Patterns of 78 (19 %) and 143 (34 %) patients respectively showing a deterioration of QoL with a mean variation of −67.2 and −67.6, respectively. There were no difference between patterns in terms of gender or age. Patients within “degradation” pattern had significantly lower performance status (p = 0.015), higher severe after-effects rate (p < 10-3) and death rate (p < 10-3). CONCLUSION: This work opens up perspectives for longitudinal data analysis with a high probability of missing values while providing a relevant graphical summary. Patterns of QoL evolution with clinical relevance may help to interpret longitudinal QoL data in Cancer studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-015-0342-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-22 /pmc/articles/PMC4578418/ /pubmed/26391356 http://dx.doi.org/10.1186/s12955-015-0342-1 Text en © Nuemi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nuemi, Gillles
Devilliers, Hervé
Le Malicot, Karine
Guimbaud, Rosine
Lepage, Côme
Quantin, Catherine
Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)
title Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)
title_full Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)
title_fullStr Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)
title_full_unstemmed Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)
title_short Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307)
title_sort construction of quality of life change patterns: example in oncology in a phase iii therapeutic trial (ffcd 0307)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578418/
https://www.ncbi.nlm.nih.gov/pubmed/26391356
http://dx.doi.org/10.1186/s12955-015-0342-1
work_keys_str_mv AT nuemigillles constructionofqualityoflifechangepatternsexampleinoncologyinaphaseiiitherapeutictrialffcd0307
AT devilliersherve constructionofqualityoflifechangepatternsexampleinoncologyinaphaseiiitherapeutictrialffcd0307
AT lemalicotkarine constructionofqualityoflifechangepatternsexampleinoncologyinaphaseiiitherapeutictrialffcd0307
AT guimbaudrosine constructionofqualityoflifechangepatternsexampleinoncologyinaphaseiiitherapeutictrialffcd0307
AT lepagecome constructionofqualityoflifechangepatternsexampleinoncologyinaphaseiiitherapeutictrialffcd0307
AT quantincatherine constructionofqualityoflifechangepatternsexampleinoncologyinaphaseiiitherapeutictrialffcd0307